🇺🇸 FDA
Patent

US 6015789

Combined use of GnRH agonist and antagonist

expired A61KA61K38/09

Quick answer

US patent 6015789 (Combined use of GnRH agonist and antagonist) held by Takeda Chemical Industries Ltd. expires Mon Jan 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Takeda Chemical Industries Ltd.
Grant date
Tue Jan 18 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K38/09